TY  - JOUR
AU  - Garland, SM
AU  - Brotherton, JML
AU  - Moscicki, AB
AU  - Kaufmann, AM
AU  - Stanley, M
AU  - Bhatla, N
AU  - Sankaranarayanan, R
AU  - de Sanjose, S
AU  - Palefsky, JM
Y2  - 2021/02/04
Y1  - 2017/12/01
SN  - 2405-8521
UR  - http://hdl.handle.net/11343/259652
AB  - It is well-established that immunocompromised people are at increased risk of HPV-related disease compared with those who are immunocompetent. Prophylactic HPV sub-unit vaccines are safe and immunogenic in immunocompromised people and it is strongly recommended that vaccination occur according to national guidelines. When delivered to immunocompromised populations, HPV vaccines should be given as a 3-dose regimen.
LA  - English
PB  - ELSEVIER SCIENCE BV
T1  - HPV vaccination of immunocompromised hosts
DO  - 10.1016/j.pvr.2017.06.002
IS  - Papillomavirus Research
VL  - 4
SP  - 35-38
L1  - /bitstream/handle/11343/259652/PMC5883202.pdf?sequence=1&isAllowed=y
ER  -